We and others have previously found that the inhibitory receptor Btla inhibits activation of inflammatory signaling by diverse lymphocyte and myeloid cells, providing a brake to the development of autoimmune disease (Bekiaris et al., 2013; Ward-Kavanagh et al., 2016; Watanabe et al., 2003). This evidence concerns the gene BTLA and autoimmune disease.